Soterix Medical
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Soterix Medical sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Soterix Medical: 8 sponsored US clinical trials, 1 recruiting.
Soterix Medical sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Unipolar Depression, with 2 trials.
Upper-quartile sponsor footprint
Soterix Medical sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Transcranial Direct Current Stimulation for Depression
NCT07042217
Ketamine Biomarker Validation
NCT07307768
Development of Neuro-Navigated Transcranial Magnetic Stimulation (TMS) Using MRI
NCT05598931
Virtual Neuro-Navigation System for Personalized Community Based TMS
NCT04956081
Home-administered tDCS for Treatment of Depression
NCT04781127
TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
NCT04994821
TDCS for Cocaine Addiction Craving
NCT03833583
Targeted Electrotherapy for Aphasia Stroke Rehabilitation (TEASER) - Phase II Multi-Center Study
NCT02540109
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
What is open in the Soterix Medical pipeline
1 recruiting of 8 indexed (13% open); 6 completed (75%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Unipolar Depression (2 trials), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Soterix Medical: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Soterix Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this Soterix Medical page
8 registered trials is a research-attention snapshot, not an endorsement of Soterix Medical or any single study.
- 1 of Soterix Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Unipolar Depression is the condition Soterix Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Unipolar Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Soterix Medical pipeline card: 8 registered trials from official public datasets.Report a data error.